Table 7.
Study | Cohort, n | Recidivism | Mortalitya | Race | Age | CCI score | Cancer stage | OR time | EBL | Transfusion | LoS | Postoperative complicationsb |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Emick et al. (2006)7 | 1643 | 26% | 22% | White P = 0.01 | P < 0.001 | – | – | P < 0.001 | P = 0.02 | P = 0.04 | P = 0.02 | P = 0.03 |
Yermilov et al. (2009)6 | 2023 | 59% | 31% | NS | P < 0.003 | P < 0.01 | P < 0.003 | – | – | – | P < 0.01 | – |
Balcom et al. (2001)13 | 733 | 11% | <2% | – | – | – | – | – | – | – | – | – |
van Geenan et al. (2001)16 | 283 | 38% | – | – | – | – | – | – | – | – | – | – |
Sperti et al. (1994)17 | 31 | 11% | – | – | – | – | – | – | – | – | – | – |
Mortality rate at 1 year post-surgery.
Postoperative complications included pancreatic fistula (P = 0.0003), wound infection (P < 0.001), intra-abdominal abscess (P < 0.001), bile leak (P = 0.04) and cholangitis (P = 0.03).
CCI, Charlson Comorbidity Index; OR, operating room; EBL, estimated blood loss; LoS, length of stay; NS, not significant.